Sandhill Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$682K Hold
8,000
0.06% 66
2025
Q4
$632K Hold
8,000
0.05% 66
2025
Q3
$640K Hold
8,000
0.04% 68
2025
Q2
$727K Hold
8,000
0.05% 60
2025
Q1
$750K Hold
8,000
0.06% 60
2024
Q4
$727K Hold
8,000
0.06% 60
2024
Q3
$830K Hold
8,000
0.06% 59
2024
Q2
$776K Hold
8,000
0.06% 60
2024
Q1
$720K Hold
8,000
0.06% 58
2023
Q4
$638K Hold
8,000
0.05% 59
2023
Q3
$569K Hold
8,000
0.05% 65
2023
Q2
$616K Hold
8,000
0.06% 64
2023
Q1
$601K Hold
8,000
0.06% 64
2022
Q4
$630K Hold
8,000
0.07% 62
2022
Q3
$562K Sell
8,000
-200
-2% -$15.7K 0.06% 63
2022
Q2
$657K Sell
8,200
-23,434
-74% -$1.83M 0.07% 63
2022
Q1
$2.4M Buy
31,634
+2,594
+9% +$205K 0.21% 45
2021
Q4
$2.48M Buy
29,040
+1,594
+6% +$124K 0.19% 41
2021
Q3
$2.07M Buy
27,446
+2,444
+10% +$194K 0.17% 45
2021
Q2
$2.03M Buy
25,002
+2,552
+11% +$209K 0.16% 46
2021
Q1
$1.77M Buy
22,450
+1,016
+5% +$79.6K 0.15% 45
2020
Q4
$1.83M Sell
21,434
-199
-0.9% -$16.5K 0.17% 42
2020
Q3
$1.67M Buy
21,633
+1,118
+5% +$85.2K 0.17% 44
2020
Q2
$1.5M Buy
20,515
+817
+4% +$58K 0.18% 43
2020
Q1
$1.31M Buy
19,698
+247
+1% +$17.4K 0.18% 45
2019
Q4
$1.34M Buy
19,451
+2,892
+17% +$197K 0.15% 43
2019
Q3
$1.22M Buy
16,559
+7,242
+78% +$525K 0.15% 41
2019
Q2
$668K Buy
9,317
+641
+7% +$45.5K 0.08% 62
2019
Q1
$595K Buy
8,676
+65
+0.8% +$4.2K 0.08% 59
2018
Q4
$513K Sell
8,611
-547
-6% -$34.2K 0.08% 61
2018
Q3
$613K Buy
9,158
+514
+6% +$34.2K 0.09% 58
2018
Q2
$560K Sell
8,644
-67
-0.8% -$4.38K 0.09% 59
2018
Q1
$624K Buy
8,711
+10
+0.1% +$720 0.1% 51
2017
Q4
$656K Buy
8,701
+345
+4% +$25.2K 0.12% 47
2017
Q3
$609K Sell
8,356
-317
-4% -$22.8K 0.12% 47
2017
Q2
$643K Buy
8,673
+225
+3% +$16.7K 0.14% 43
2017
Q1
$618K Sell
8,448
-1,413
-14% -$98.9K 0.14% 41
2016
Q4
$645K Buy
9,861
+593
+6% +$40.7K 0.18% 45
2016
Q3
$687K Buy
9,268
+694
+8% +$51.3K 0.21% 34
2016
Q2
$628K Buy
8,574
+84
+1% +$5.98K 0.2% 35
2016
Q1
$600K Sell
8,490
-1,816
-18% -$121K 0.2% 35
2015
Q4
$687K Buy
10,306
+77
+0.8% +$5.12K 0.22% 34
2015
Q3
$649K Buy
10,229
+50
+0.5% +$3.27K 0.22% 39
2015
Q2
$666K Sell
10,179
-2,375
-19% -$161K 0.2% 45
2015
Q1
$870K Buy
12,554
+10
+0.1% +$691 0.3% 39
2014
Q4
$868K Buy
12,544
+1,605
+15% +$108K 0.29% 36
2014
Q3
$713K Buy
10,939
+3,128
+40% +$206K 0.25% 53
2014
Q2
$533K Buy
7,811
+562
+8% +$37.7K 0.19% 65
2014
Q1
$470K Buy
7,249
+104
+1% +$6.55K 0.18% 64
2013
Q4
$466K Buy
7,145
+211
+3% +$13.5K 0.19% 60
2013
Q3
$411K Buy
6,934
+20
+0.3% +$1.19K 0.18% 57
2013
Q2
$396K Buy
+6,914
New +$410K 0.2% 55

Other funds holding CL

Sandhill Capital Partners's CL Position: Q1 2026 in Review

Sandhill Capital Partners held its Colgate-Palmolive (CL) position steady in Q1 2026 at 8,000 shares worth $682K. The position accounts for 0.06% of the portfolio, ranked #66.

Sandhill Capital Partners first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.48M in Q4 2021. 1,950 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Sandhill Capital Partners held 8,000 shares of Colgate-Palmolive worth $682K as of Q1 2026.
  • Sandhill Capital Partners left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.06% of Sandhill Capital Partners's portfolio in Q1 2026, its #66 holding.
  • Sandhill Capital Partners first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Sandhill Capital Partners's Colgate-Palmolive position peaked at $2.48M in Q4 2021.
  • 1,950 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Sandhill Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.